Decision: Favourable

Decisions Table

Study Title:

A multicentre, single-arm phase II trial of adagrasib in patients with KRASG12C-mutant NSCLC, including the elderly (70 years) or patients with poor performance status

  • NREC Code:

    23-NREC-CT-022

  • Decision:

    Favourable

  • Meeting Date:

    24/03/2023

  • Study Type:

    CT application

  • Principal Investigator:

    Dr Jarushka Naidoo

  • PI Institution:

    Beaumont Hospital

  • Sponsor:

    ETOP IBCSG Partners Foundation

Scroll to Top